Regeneron Pharmaceuticals, Inc. (LON: 0R2M)
London flag London · Delayed Price · Currency is GBP · Price in USD
718.00
+10.71 (1.51%)
Dec 23, 2024, 7:14 PM BST

Regeneron Pharmaceuticals Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
61,47973,32963,95348,76437,34730,994
Upgrade
Market Cap Growth
18.47%14.66%31.15%30.57%20.50%-2.19%
Upgrade
Enterprise Value
49,02763,13155,41442,32434,99827,028
Upgrade
Last Close Price
567.25688.75591.37470.42356.82283.08
Upgrade
PE Ratio
17.7023.6217.768.1814.5119.40
Upgrade
PS Ratio
8.197.126.334.116.006.26
Upgrade
PB Ratio
3.873.603.403.524.623.70
Upgrade
P/TBV Ratio
4.023.753.543.524.623.70
Upgrade
P/FCF Ratio
32.9924.1017.4110.1125.4520.52
Upgrade
P/OCF Ratio
26.7120.3315.379.3219.4816.89
Upgrade
EV/Sales Ratio
4.436.135.483.575.625.46
Upgrade
EV/EBITDA Ratio
13.2917.2812.516.1712.2514.79
Upgrade
EV/EBIT Ratio
14.8619.0013.376.3713.0416.20
Upgrade
EV/FCF Ratio
19.1020.7515.098.7823.8517.89
Upgrade
Debt / Equity Ratio
0.090.110.120.140.240.06
Upgrade
Debt / EBITDA Ratio
0.590.600.520.290.690.29
Upgrade
Debt / FCF Ratio
0.790.720.630.411.350.36
Upgrade
Asset Turnover
0.400.420.450.750.530.49
Upgrade
Inventory Turnover
2.442.512.372.742.262.51
Upgrade
Quick Ratio
4.344.824.162.982.862.86
Upgrade
Current Ratio
5.285.695.063.563.633.67
Upgrade
Return on Equity (ROE)
17.17%16.26%20.94%54.21%31.77%21.32%
Upgrade
Return on Assets (ROA)
7.41%8.49%11.42%26.39%14.33%10.41%
Upgrade
Return on Capital (ROIC)
8.65%9.76%13.31%31.95%17.95%12.99%
Upgrade
Earnings Yield
5.32%4.23%5.63%12.23%6.89%5.15%
Upgrade
FCF Yield
3.03%4.15%5.74%9.89%3.93%4.87%
Upgrade
Buyback Yield / Dilution
-1.16%-0.18%-1.16%2.52%-0.44%0.17%
Upgrade
Total Shareholder Return
-1.16%-0.18%-1.16%2.52%-0.44%0.17%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.